Loading clinical trials...
Loading clinical trials...
The primary aim of this trial is to investigate the feasibility of an exercise program consisting of respiratory exercises, aerobic exercises and strengthening exercises in mild to moderate Alzheimer's disease. The trial also aims to investigate the effectiveness of the exercise program on respiratory symptoms, exercise capacity, cognition, physical performance, depression, sleepiness, activities of daily living and quality of life. Patients will be divided into exercise (intervention) and control group by randomization method. The study is planned to be performed with a total of 60 patients, 30 in each group. The patients in the exercise group will be given breathing exercises aerobic exercises and strengthening exercises for 2 days a week for 12 weeks, about 30-40 minutes while the patients in the control group will be provided with suggestions, home exercise program and daily life activities
Exercise group was trained 3 times a week under the supervision of a physiotherapist and encouraged to exercise at home on other days
Age
65 - No limit years
Sex
ALL
Healthy Volunteers
No
Elvan Keleş
İzmi̇r, Turkey (Türkiye)
Start Date
July 16, 2018
Primary Completion Date
October 8, 2018
Completion Date
July 30, 2020
Last Updated
July 17, 2019
60
ACTUAL participants
Exercise
OTHER
Lead Sponsor
Dokuz Eylul University
Collaborators
NCT04123314
NCT07178210
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions